Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q28371571)
Watch
English
BRAF KIAA1549::BRAF
genetic variant
KIAA1549-BRAF
KIAA1549::BRAF
In more languages
edit
Statements
instance of
transcript fusion
1 reference
stated in
CIViC database
retrieved
23 May 2022
reference URL
https://civic.genome.wustl.edu/links/variants/618
chromosome
human chromosome 7
genomic assembly
Genome assembly GRCh37
1 reference
stated in
CIViC database
retrieved
23 May 2022
reference URL
https://civic.genome.wustl.edu/links/variants/618
genomic start
138545885
genomic assembly
Genome assembly GRCh37
1 reference
stated in
CIViC database
retrieved
23 May 2022
reference URL
https://civic.genome.wustl.edu/links/variants/618
140434279
genomic assembly
Genome assembly GRCh37
1 reference
stated in
CIViC database
retrieved
23 May 2022
reference URL
https://civic.genome.wustl.edu/links/variants/618
genomic end
138666064
genomic assembly
Genome assembly GRCh37
1 reference
stated in
CIViC database
retrieved
23 May 2022
reference URL
https://civic.genome.wustl.edu/links/variants/618
140487384
genomic assembly
Genome assembly GRCh37
1 reference
stated in
CIViC database
retrieved
23 May 2022
reference URL
https://civic.genome.wustl.edu/links/variants/618
biological variant of
BRAF
1 reference
stated in
CIViC database
retrieved
23 May 2022
reference URL
https://civic.genome.wustl.edu/links/variants/618
positive therapeutic predictor for
trametinib
medical condition treated
skin melanoma
determination method
CIViC evidence level C
rating
CIViC 1-star trust rating
1 reference
curator
CIViC database
retrieved
23 May 2022
reference URL
https://civic.genome.wustl.edu/links/evidence/1571
stated in
Clinical activity of the MEK inhibitor trametinib in metastatic melanoma containing BRAF kinase fusion
trametinib / everolimus combination therapy
determination method
CIViC evidence level D
rating
CIViC 2-star trust rating
medical condition treated
pediatric low-grade glioma
1 reference
curator
CIViC database
retrieved
23 May 2022
reference URL
https://civic.genome.wustl.edu/links/evidence/7199
stated in
Overcoming resistance to single-agent therapy for oncogenic BRAF gene fusions via combinatorial targeting of MAPK and PI3K/mTOR signaling pathways.
trametinib
determination method
CIViC evidence level D
rating
CIViC 3-star trust rating
medical condition treated
childhood pilocytic astrocytoma
1 reference
curator
CIViC database
retrieved
23 May 2022
reference URL
https://civic.genome.wustl.edu/links/evidence/8944
stated in
Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing
sorafenib / temsirolimus / Bevacizumab combination therapy
determination method
CIViC evidence level C
rating
CIViC 2-star trust rating
medical condition treated
spindle cell sarcoma
1 reference
curator
CIViC database
retrieved
23 May 2022
reference URL
https://civic.genome.wustl.edu/links/evidence/1664
stated in
Targeted therapy by combined inhibition of the RAF and mTOR kinases in malignant spindle cell neoplasm harboring the KIAA1549-BRAF fusion protein
negative therapeutic predictor for
vemurafenib
determination method
CIViC evidence level D
rating
CIViC 2-star trust rating
medical condition treated
childhood pilocytic astrocytoma
1 reference
curator
CIViC database
retrieved
23 May 2022
reference URL
https://civic.genome.wustl.edu/links/evidence/7402
stated in
Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing
sorafenib
determination method
CIViC evidence level D
rating
CIViC 2-star trust rating
medical condition treated
childhood pilocytic astrocytoma
1 reference
curator
CIViC database
retrieved
23 May 2022
reference URL
https://civic.genome.wustl.edu/links/evidence/7402
stated in
Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing
positive diagnostic predictor for
pilocytic astrocytoma
determination method
CIViC evidence level B
rating
CIViC 5-star trust rating
1 reference
curator
CIViC database
retrieved
23 May 2022
reference URL
https://civic.genome.wustl.edu/links/evidence/7148
stated in
Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma
pilocytic astrocytoma
determination method
CIViC evidence level B
rating
CIViC 4-star trust rating
1 reference
curator
CIViC database
retrieved
23 May 2022
reference URL
https://civic.genome.wustl.edu/links/evidence/7319
stated in
Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas
positive prognostic predictor for
pediatric low-grade glioma
determination method
CIViC evidence level B
rating
CIViC 4-star trust rating
2 references
curator
CIViC database
retrieved
23 May 2022
reference URL
https://civic.genome.wustl.edu/links/evidence/7193
stated in
Pediatric low-grade gliomas can be molecularly stratified for risk
curator
CIViC database
retrieved
23 May 2022
reference URL
https://civic.genome.wustl.edu/links/evidence/7200
stated in
BRAF-KIAA1549 fusion predicts better clinical outcome in pediatric low-grade astrocytoma.
Identifiers
CIViC variant ID
618
1 reference
stated in
CIViC database
retrieved
23 May 2022
reference URL
https://civic.genome.wustl.edu/links/variants/618
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit